reports
Elma Electronic AG: 1 director
A director at Elma Electronic AG bought 85 shares at 1,030.000CHF and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Sy...
Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring) A Study of AC5® Advanced Wound System in Patients with Lower Extremity Wounds to be Featured in a Clinical Poster FRAMINGHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical products, today announced that the Company’s first commercial product, AC5® Advanced Wound System (“AC5”), will be featured at the 2024 Symposium on Advanced Wound Care Spring M...
Loihde Oyj: 1 director
A director at Loihde Oyj bought 2,500 shares at 13.911EUR and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Kuehne + Nagel International AG: 1 director
A director at Kuehne + Nagel International AG bought 50,163 shares at 244.520CHF and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...
- FIMA Research
Fima Daily Insight 06 May 2024
Please find enclosed our daily market report.Market CommentCroatia Atlantic grupa buys back 8,812 own shares Đuro Đaković is launching the production of demining machines Slovenia Slovenia's exports down 2.1% in March, imports decline by 6.7% IMF projects Slovenia to overtake Italy in purchasing power by 2029 Romania Romania's manufacturing PMI turns positive in April Bulgaria Bulgaria restricts gambling, gambling ads
BioNTech veröffentlicht Ergebnisse für das erste Quartal 2024 sowie In...
BioNTech veröffentlicht Ergebnisse für das erste Quartal 2024 sowie Informationen zur Geschäftsentwicklung BioNTech ist auf einem gutem Weg, das Jahresziel von zehn oder mehr potenziell zulassungsrelevanten Studien in der Pipeline bis Ende 2024 zu erreichen: weitere Phase-3-Studie mit der Behandlung der ersten Patientin gestartet, in der BNT323/DB-1303 bei Patientinnen und Patienten mit metastasierendem Brustkrebs (HR+, geringes HER2-Expressionslevel), die keine Chemotherapie erhalten haben, untersucht wird; eine weitere Phase-3-Studie mit BNT323/DB-1303 bei wiederkehrendem Endometriumkarzi...
BioNTech Announces First Quarter 2024 Financial Results and Corporate ...
BioNTech Announces First Quarter 2024 Financial Results and Corporate Update Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in Phase 3 clinical trial evaluating BNT323/DB-1303 in HR+ HER2-low chemotherapy-naïve metastatic breast cancer patients, and a second Phase 3 trial with BNT323/DB-1303 in recurrent endometrial cancer planned to start soonPresented clinical data at the American Association for Cancer Research (“AACR”) Annual Meeting for individualized and off-the-shelf mRNA-based cancer vaccine candidates based on ...
Pfizer Announces New Chief Strategy and Innovation Officer
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation Officer, Executive Vice President. Dr. Baum will be a member of Pfizer’s Executive Leadership Team reporting to Chairman and Chief Executive Officer, Dr. Albert Bourla. He joins Pfizer from Citi, where he served as Head of Global Healthcare, Managing Director Equity Research. Prior to joining Citi in 2011, Dr. Baum covered European Pharmaceuticals at Morgan Stanley for 14 years and earlier in his career was a practicing physician at the Royal Nation...
Healthcare Realty Trust Announces Strategic Joint Venture With KKR
Healthcare Realty Trust Announces Strategic Joint Venture With KKR Contributes seed portfolio valued at $383 million to the JV, resulting in proceeds of approximately $300 million Additional KKR capital commitment of up to $600 million to increase the potential value of the JV to more than $1 billion NASHVILLE, Tenn., May 06, 2024 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced that it has entered into a strategic joint venture (JV) relationship with KKR to jointly own and invest in quality medical outpatient buildings. Healthcare Realty ex...
Meritage Homes Announces Offering of Convertible Senior Notes
Meritage Homes Announces Offering of Convertible Senior Notes SCOTTSDALE, Ariz., May 06, 2024 (GLOBE NEWSWIRE) -- Meritage Homes Corporation (NYSE: MTH, “Meritage” or the “Company”), the fifth-largest homebuilder in the U.S., today announced that it has commenced an offering of $500 million aggregate principal amount of its Convertible Senior Notes due 2028 (the “notes”), subject to market and other conditions. The Company also expects to grant the initial purchasers of the notes a 13-day option to purchase up to $75 million of aggregate principal amount of additional notes. The notes wi...
EQS-News: Immunic to Participate in Investor and Scientific Conference...
Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Investor and Scientific Conferences in May 06.05.2024 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Investor and Scientific Conferences in May NEW YORK, May 6, 2024 – (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following investor and scientific conferences in May: May 12-...
Oculis to Present at Bank of America Global Healthcare Conference
Oculis to Present at Bank of America Global Healthcare Conference ZUG, Switzerland, and BOSTON, USA, May 06, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”) a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ management will be attending and presenting at the Bank of America Healthcare Conference taking place on May 14-16, 2024 in Las Vegas, NV. Riad Sherif, M.D., Chief Executive Officer of Oculis, will deliver a company presentation on Wednesday, May 15th at 11:20am PT at ...
Teleflex Announces Quarterly Dividend
Teleflex Announces Quarterly Dividend WAYNE, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 14, 2024, to shareholders of record at the close of business on May 15, 2024. Additional information about Teleflex can be obtained from the company’s website at . About Teleflex Incorporated Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We ...
Freshpet, Inc. Reports First Quarter 2024 Financial Results
Freshpet, Inc. Reports First Quarter 2024 Financial Results Company Updates 2024 Outlook; Raises Adjusted EBITDA GuidanceNet Sales Driven by Volume-Based Growth Profitability Improvement Driven by Lower Input, Quality and Logistics Costs SECAUCUS, N.J., May 06, 2024 (GLOBE NEWSWIRE) -- Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today reported financial results for its first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights Compared to Prior Year Period Net sales of $223.8 million, an increase of 33.6%.Gross margin of 39.4%, compared to the prior yea...
K92 Mining Announces Latest Drilling Results Extending Multiple High-G...
K92 Mining Announces Latest Drilling Results Extending Multiple High-Grade Zones and New Dilatant Zone Discovered VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) is pleased to announce its latest high-grade results from the ongoing surface and underground diamond drilling of the Kora, Kora South, Judd and Judd South deposits in addition to the Kora and Judd Northern Deeps targets at the Kainantu Gold Mine in Papua New Guinea. Multiple dilatant zones intersected at Kora’s K2 Vein, including a new dilatant zo...
Hut 8 Operations Update for April 2024
Hut 8 Operations Update for April 2024 26.6 EH/s and 1.2 GW under management Salt Creek site fully energized and Cedarvale site partially energized MIAMI, May 06, 2024 (GLOBE NEWSWIRE) -- Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), a leading, vertically integrated operator of large-scale energy infrastructure and one of North America’s largest Bitcoin miners, today released its operations update for April 2024. “Amidst the backdrop of the halving, the operational capabilities of our team enabled us to maximize deployed hashrate ...
Lilium Announces Firm Order of 20 Lilium Jets from U.S. Operator Urban...
Lilium Announces Firm Order of 20 Lilium Jets from U.S. Operator UrbanLink UrbanLink’s firm purchase order of 20 Lilium Jets, with an option for 20 more, includes scheduled pre-delivery payments.The agreement marks a critical aviation milestone as UrbanLink becomes the first airline in the U.S. fully committed to integrating eVTOL aircraft into its fleet.UrbanLink will begin operations with a regional network connecting cities in South Florida. MIAMI, May 06, 2024 (GLOBE NEWSWIRE) -- Lilium N.V. (NASDAQ:LILM), developer of the first all-electric vertical take-off and landing (“eVTOL”) je...
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armo...
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider MILAN, Italy and NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power of hematopoietic stem cells to provide durable and safe treatments for solid tumors, announces that it held its Ordinary and Extraordinary Shareholders' Meeting on May 2, 2024. At the Ordinary and Extraordinary Shareholders' Meeting, the Company's shareholders approved the appointment of five directors to the...
Net Asset Value(s)
Net Asset Value(s) WisdomTree Issuer plc – Daily Fund Prices 03-May-24 WisdomTree Artificial Intelligence UCITS ETF - USD Acc03/05/2024IE00BDVPNG1314054630USD859,780,170.4661.1742WisdomTree AT1 CoCo Bond UCITS ETF - EUR Hedged03/05/2024IE00BFNNN2361621917EUR133,825,079.8382.5104WisdomTree AT1 CoCo Bond UCITS ETF - GBP Hedged03/05/2024IE00BFNNN459167509GBP14,476,027.4186.4194WisdomTree AT1 CoCo Bond UCITS ETF - USD03/05/2024IE00BZ0XVF52687178USD56,961,746.9482.8923WisdomTree AT1 CoCo Bond UCITS ETF - USD Acc03/05/2024IE00BZ0XVG6950789USD5,776,687.33113.7389WisdomTree ...
Verkkokauppa.com Oyj: Announcement of a change in shareholding accordi...
Verkkokauppa.com Oyj: Announcement of a change in shareholding according to Chapter 9, Section 10 of the Finnish Securities Market Act; Samuli Seppälä’s holding in Verkkokauppa.com Verkkokauppa.com Oyj: Announcement of a change in shareholding according to Chapter 9, Section 10 of the Finnish Securities Market Act; Samuli Seppälä’s holding in Verkkokauppa.com Verkkokauppa.com Oyj Stock Exchange Release – FLAGGING NOTIFICATION 6 May 2024, at 13:20pm (EEST) Verkkokauppa.com Oyj has on 3 May 2024 received a notification under Chapter 9, Section 5 of the Finnish Securities Market Act accordin...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.